insights_auto
Prečo akcie ALMKT klesli 2,79%?
Preskúmať podrobnejšiechevron_right
ALMKT:EPA
Mauna Kea Technologies SA
0,087 €
arrow_downward
-2,79%(-0,0025) 1 d.
20. 11., 17:35:11 GMT+1 · EUR
search
Všetky symboly
| Symbol | Cena | Zmena | % zmeny |
|---|
insights_autoGenerujú sa najdôležitejšie štatistiky pre ALMKT…
Otvoriť
0,09 €
Vysoká
0,09 €
Nízka
0,09 €
Trh. kap.
16,66 mil.
Priem. obj.
406,96 tis.
Objem
258,62 tis.
Pomer cena/zárobky
0,74
Max. za 52 týž.
0,23 €
Min. za 52 týž.
0,07 €
Výnosy na akciu
0,12 €
Akcie v obehu
195,26 mil.
Počet zamestnancov
56
Otvoriť
0,09 €
Vysoká
0,09 €
Nízka
0,09 €
Trh. kap.
16,66 mil.
Priem. obj.
406,96 tis.
Objem
258,62 tis.
Pomer cena/zárobky
0,74
Max. za 52 týž.
0,23 €
Min. za 52 týž.
0,07 €
Výnosy na akciu
0,12 €
Akcie v obehu
195,26 mil.
Počet zamestnancov
56
Spravodajstvo
Z internetových zdrojov a od spravodajských partnerov
Yahoo Finance
·
pred 5 hodinami
The S&P 500 Has More Than Tripled in 10 Years, Even After Its Latest Pullback. Here’s What $1,000 in VOO Could Have Become.
Marietta Daily Journal
·
pred 7 hodinami
S&P 500 sinks 3.7% and Nasdaq composite goes negative for the year as tech sell-off worsens
WDIO.com
·
pred 1 dňom
S&P 500 sinks 3.7% and the Nasdaq composite goes negative for the year
Yahoo Finance
·
pred 9 hodinami
Wall St ends sharply lower on AI selloff, S&P 500, Dow in correction
Profil
Mauna Kea Technologies is a global medical device company focused on endomicroscopy, the field of microscopic imaging during endoscopy procedures. The company researches, develops and markets tools to visualize, detect, and rule out abnormalities including malignant and pre-malignant tumors or lesions in the gastrointestinal and pulmonary tracts.
The company makes Cellvizio, a probe-based Confocal Laser Endomicroscopy system, which provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues.
Cellvizio is used in medical applications such as gastrointestinal endoscopy, pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real-time.
Cellvizio went public in July 2011 and trades on the Euronext Paris exchange. Wikipedia
Informácie o subjekte Mauna Kea Technologies SA
Generálny riaditeľSacha Loiseau
Zamestnanci56
Dátum založenia2000
Hlavné sídlo-
OdvetvieHealth Care
Odvetvie-